S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
A Phase II Trial of Combination Thalidomide Plus Temozolomide in Patients With Metastatic Malignant Melanoma
3 other identifiers
interventional
64
1 country
132
Brief Summary
RATIONALE: Thalidomide may stop the growth of melanoma by blocking blood flow to the tumor. It may also stimulate the immune system in different ways and stop tumor cells from growing. Drugs used in chemotherapy, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving thalidomide together with temozolomide may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving thalidomide together with temozolomide works in treating patients with stage IV melanoma that cannot be removed by surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Jun 2005
Typical duration for phase_2
132 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 3, 2005
CompletedFirst Posted
Study publicly available on registry
March 4, 2005
CompletedStudy Start
First participant enrolled
June 1, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2009
CompletedAugust 22, 2012
August 1, 2012
2.1 years
March 3, 2005
August 20, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Progression-free survival at 6 months
6 months after registration
Objective response (confirmed and unconfirmed complete and partial responses)
Week 9, every 8 weeks thereafter until progression
6-month overall survival
six months after registration
Study Arms (1)
Thalidomide and Temozolomide
EXPERIMENTALPatients receive oral thalidomide once daily on days 1-56 and temozolomide once daily on days 1-42. Courses repeat every 56 days in the absence of disease progression or unacceptable toxicity.
Interventions
75 mg/m\^2/day PO daily for 6 weeks followed by a 2-week break
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
- SWOG Cancer Research Networklead
- National Cancer Institute (NCI)collaborator
Study Sites (132)
Alaska Regional Hospital Cancer Center
Anchorage, Alaska, 99508, United States
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas, 72205, United States
Eden Medical Center
Castro Valley, California, 94546, United States
North Bay Cancer Center
Fairfield, California, 94533, United States
Saint Rose Hospital
Hayward, California, 94545, United States
USC/Norris Comprehensive Cancer Center and Hospital
Los Angeles, California, 90089-9181, United States
Highland General Hospital at St. George's University School of Medicine
Oakland, California, 94602, United States
Alta Bates Summit Medical Center - Summit Campus
Oakland, California, 94609, United States
CCOP - Bay Area Tumor Institute
Oakland, California, 94609, United States
Valley Care Medical Center
Pleasanton, California, 94588, United States
Doctors Medical Center - San Pablo Campus
San Pablo, California, 94806, United States
West Florida Cancer Institute at West Florida Hospital - Pensacola
Pensacola, Florida, 32514, United States
Northeast Georgia Medical Center
Gainesville, Georgia, 30501, United States
Curtis & Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center
Savannah, Georgia, 31403-3089, United States
St. Luke's Mountain States Tumor Institute - Boise
Boise, Idaho, 83712, United States
Decatur Memorial Hospital Cancer Care Institute
Decatur, Illinois, 62526, United States
Veterans Affairs Medical Center - Hines
Hines, Illinois, 60141, United States
Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois, 60153, United States
Regional Cancer Center at Memorial Medical Center
Springfield, Illinois, 62781-0001, United States
Genesis Regional Cancer Center at Genesis Medical Center
Davenport, Iowa, 52803, United States
Tammy Walker Cancer Center at Salina Regional Health Center
Salina, Kansas, 67401, United States
Stormont-Vail Cancer Center
Topeka, Kansas, 66604, United States
St. Francis Comprehensive Cancer Center
Topeka, Kansas, 66606, United States
Wesley Medical Center
Wichita, Kansas, 67214, United States
Christus Schumpert Cancer Treatment Center
Shreveport, Louisiana, 71101, United States
Battle Creek Health System Cancer Care Center
Battle Creek, Michigan, 49017, United States
Mecosta County Medical Center
Big Rapids, Michigan, 49307, United States
Josephine Ford Cancer Center at Henry Ford Hospital
Detroit, Michigan, 48202, United States
CCOP - Grand Rapids
Grand Rapids, Michigan, 49503, United States
Lacks Cancer Center at Saint Mary's Health Care
Grand Rapids, Michigan, 49503, United States
Spectrum Health Hospital - Butterworth Campus
Grand Rapids, Michigan, 49503, United States
Metro Health Hospital
Grand Rapids, Michigan, 49506, United States
Holland Community Hospital
Holland, Michigan, 49423, United States
Ted B. Wahby Cancer Center at Mount Clemens General Hospital
Mount Clemens, Michigan, 48043, United States
Hackley Hospital
Muskegon, Michigan, 49442, United States
Mercy Regional Cancer Center at Mercy Hospital
Port Huron, Michigan, 48060, United States
Munson Medical Center
Traverse City, Michigan, 49684, United States
Freeman Cancer Institute at Freeman Health System
Joplin, Missouri, 64804, United States
CCOP - Kansas City
Kansas City, Missouri, 64131, United States
CCOP - Cancer Research for the Ozarks
Springfield, Missouri, 65802, United States
St. John's Regional Health Center
Springfield, Missouri, 65804, United States
Hulston Cancer Center at Cox Medical Center South
Springfield, Missouri, 65807, United States
CCOP - Montana Cancer Consortium
Billings, Montana, 59101, United States
Hematology-Oncology Centers of the Northern Rockies - Billings
Billings, Montana, 59101, United States
Northern Rockies Radiation Oncology Center
Billings, Montana, 59101, United States
St. Vincent Healthcare
Billings, Montana, 59101, United States
Billings Clinic Cancer Center
Billings, Montana, 59107-5100, United States
Deaconess Billings Clinic - Downtown
Billings, Montana, 59107-7000, United States
Bozeman Deaconess Hospital
Bozeman, Montana, 59715, United States
St. James Community Hospital
Butte, Montana, 59701, United States
Big Sky Oncology
Great Falls, Montana, 59405, United States
Sletten Regional Cancer Institute at Benefis Healthcare
Great Falls, Montana, 59405, United States
Unknown Facility
Great Falls, Montana, 59405, United States
St. Peter's Hospital
Helena, Montana, 59601, United States
Glacier Oncology, PLLC
Kalispell, Montana, 59901, United States
Kalispell Medical Oncology
Kalispell, Montana, 59901, United States
Kalispell Regional Medical Center
Kalispell, Montana, 59901, United States
Community Medical Center
Missoula, Montana, 59801, United States
Guardian Oncology and Center for Wellness
Missoula, Montana, 59804, United States
Montana Cancer Specialists at Montana Cancer Center
Missoula, Montana, 59807-7877, United States
Montana Cancer Center at St. Patrick Hospital and Health Sciences Center
Missoula, Montana, 59807, United States
Good Samaritan Cancer Center at Good Samaritan Hospital
Kearney, Nebraska, 68848-1990, United States
Tucker Center for Cancer Care at Orange Regional Medical Center
Middletown, New York, 10940-4199, United States
Highland Hospital of Rochester
Rochester, New York, 14620, United States
Interlakes Oncology/Hematology PC
Rochester, New York, 14623, United States
James P. Wilmot Cancer Center at University of Rochester Medical Center
Rochester, New York, 14642, United States
CaroMont Cancer Center at Gaston Memorial Hospital
Gastonia, North Carolina, 28053, United States
Wayne Memorial Hospital, Incorporated
Goldsboro, North Carolina, 27534, United States
Wayne Radiation Oncology
Goldsboro, North Carolina, 27534, United States
Rutherford Hospital
Rutherfordton, North Carolina, 28139, United States
Wilson Medical Center
Wilson, North Carolina, 27893-3428, United States
Adena Regional Medical Center
Chillicothe, Ohio, 45601, United States
Charles M. Barrett Cancer Center at University Hospital
Cincinnati, Ohio, 45267, United States
Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio, 44195, United States
Riverside Methodist Hospital Cancer Care
Columbus, Ohio, 43214-3998, United States
CCOP - Columbus
Columbus, Ohio, 43215, United States
Grant Riverside Cancer Services
Columbus, Ohio, 43215, United States
Mount Carmel Health - West Hospital
Columbus, Ohio, 43222, United States
Doctors Hospital at Ohio Health
Columbus, Ohio, 43228, United States
Grady Memorial Hospital
Delaware, Ohio, 43015, United States
Community Oncology Group at Cleveland Clinic Cancer Center
Independence, Ohio, 44131, United States
Fairfield Medical Center
Lancaster, Ohio, 43130, United States
Strecker Cancer Center at Marietta Memorial Hospital
Marietta, Ohio, 45750, United States
Licking Memorial Cancer Care Program at Licking Memorial Hospital
Newark, Ohio, 43055, United States
Mercy Medical Center
Springfield, Ohio, 45504, United States
Community Hospital of Springfield and Clark County
Springfield, Ohio, 45505, United States
Mount Carmel Cancer Services at Mount Carmel St. Ann's Hospital
Westerville, Ohio, 43081, United States
Cleveland Clinic - Wooster
Wooster, Ohio, 44691, United States
Tod Children's Hospital - Forum Health
Youngstown, Ohio, 44501, United States
Genesis - Good Samaritan Hospital
Zanesville, Ohio, 43701, United States
Legacy Mount Hood Medical Center
Gresham, Oregon, 97030, United States
Providence Milwaukie Hospital
Milwaukie, Oregon, 97222, United States
Legacy Good Samaritan Hospital & Medical Center Comprehensive Cancer Center
Portland, Oregon, 97210, United States
Providence Cancer Center at Providence Portland Medical Center
Portland, Oregon, 97213-2967, United States
CCOP - Columbia River Oncology Program
Portland, Oregon, 97225, United States
Providence St. Vincent Medical Center
Portland, Oregon, 97225, United States
Legacy Emanuel Hospital and Health Center & Children's Hospital
Portland, Oregon, 97227, United States
Legacy Meridian Park Hospital
Tualatin, Oregon, 97062, United States
AnMed Health Cancer Center
Anderson, South Carolina, 29621, United States
Roper St. Francis Cancer Center at Roper Hospital
Charleston, South Carolina, 29401, United States
CCOP - Upstate Carolina
Spartanburg, South Carolina, 29303, United States
Gibbs Regional Cancer Center at Spartanburg Regional Medical Center
Spartanburg, South Carolina, 29303, United States
U.T. Cancer Institute at University of Tennessee Medical Center
Knoxville, Tennessee, 37920-6999, United States
Medical City Dallas Hospital
Dallas, Texas, 75230, United States
Brooke Army Medical Center
Fort Sam Houston, Texas, 78234, United States
Wilford Hall Medical Center
Lackland Air Force Base, Texas, 78236, United States
CCOP - Scott and White Hospital
Temple, Texas, 76508, United States
American Fork Hospital
American Fork, Utah, 84003, United States
Logan Regional Hospital
Logan, Utah, 84321, United States
Cottonwood Hospital Medical Center
Murray, Utah, 84107, United States
McKay-Dee Hospital Center
Ogden, Utah, 84403, United States
Utah Valley Regional Medical Center - Provo
Provo, Utah, 84604, United States
Latter Day Saints Hospital
Salt Lake City, Utah, 84103, United States
Utah Cancer Specialists at UCS Cancer Center
Salt Lake City, Utah, 84106, United States
Dixie Regional Medical Center - East Campus
St. George, Utah, 84770, United States
Danville Regional Medical Center
Danville, Virginia, 24541, United States
St. Joseph Cancer Center
Bellingham, Washington, 98225, United States
Olympic Hematology and Oncology
Bremerton, Washington, 98310, United States
Skagit Valley Hospital Cancer Care Center
Mount Vernon, Washington, 98273, United States
Fred Hutchinson Cancer Research Center
Seattle, Washington, 98104, United States
Harborview Medical Center
Seattle, Washington, 98104, United States
Minor and James Medical, PLLC
Seattle, Washington, 98104, United States
Group Health Central Hospital
Seattle, Washington, 98112, United States
Swedish Cancer Institute at Swedish Medical Center - First Hill Campus
Seattle, Washington, 98122-4307, United States
Polyclinic First Hill
Seattle, Washington, 98122, United States
University Cancer Center at University of Washington Medical Center
Seattle, Washington, 98195-6043, United States
North Puget Oncology at United General Hospital
Sedro-Woolley, Washington, 98284, United States
Cancer Care Northwest - Spokane South
Spokane, Washington, 99202, United States
Southwest Washington Medical Center Cancer Center
Vancouver, Washington, 98668, United States
Wenatchee Valley Medical Center
Wenatchee, Washington, 98801-2028, United States
Community Comprehensive Cancer Center at Camden-Clark Memorial Hospital
Parkersburg, West Virginia, 26102, United States
Welch Cancer Center at Sheridan Memorial Hospital
Sheridan, Wyoming, 82801, United States
Related Publications (1)
Clark JI, Moon J, Hutchins LF, Sosman JA, Kast WM, Da Silva DM, Liu PY, Thompson JA, Flaherty LE, Sondak VK. Phase 2 trial of combination thalidomide plus temozolomide in patients with metastatic malignant melanoma: Southwest Oncology Group S0508. Cancer. 2010 Jan 15;116(2):424-31. doi: 10.1002/cncr.24739.
PMID: 19918923RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Joseph I. Clark, MD
Loyola University
- PRINCIPAL INVESTIGATOR
Laura F. Hutchins, MD
University of Arkansas
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 3, 2005
First Posted
March 4, 2005
Study Start
June 1, 2005
Primary Completion
July 1, 2007
Study Completion
August 1, 2009
Last Updated
August 22, 2012
Record last verified: 2012-08